Marker Therapeutics, Inc. (MRKR) — Analyst estimates
Consensus analyst estimates for Marker Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 682.1K | -0.32 | 1 |
| 2027 | 1.10M | -0.3 | 1 |
| 2028 | 83.87M | 0.47 | 3 |
| 2029 | 163.59M | 1.97 | 1 |
| 2030 | 316.9M | 5.41 | 1 |
Consensus analyst estimates by fiscal year.